Key Dates
None
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
The NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative intends to issue a Funding Opportunity Announcement (FOA) for BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The FOA is expected to be published in Summer 2022 with an expected application due date in Fall 2022
This FOA will utilize the UG3/UH3 activity code. Details of the planned FOA are provided below.
This funding opportunity solicits applications for team-centric development and validation of non-invasive imaging technologies that could have a transformative impact on the study of brain function/connectivity. Applications are expected to turn a novel concept into a functional prototype using a UG3/UH3 phased grant mechanism. The feasibility should be established by the end of its first phase and serve as a foundation for the transition to its second phase. Fully developing the technology into a functional prototype and validating it by in-vivo animal or human function/connectivity imaging are anticipated in the second phase. Reaserchers are encouraged to form multidisciplinary team consiting of tool developers and end-users for development efforts that explore novel directions and would bring substantial performance improvements to advance non-invsive imaging approaches in neuroscience research. Awards will be integrated into the BRAIN Non-Invasive Imaging Consortium, as a coordinated network on brain function/connectivity imaging.
TBD
Up to $18M each fiscal
Up to 4 awards each fiscal year
Application budgets are limited to $300,000 in direct costs excluding consortium F&A in any year for the UG3 phase.
Applications should rarely exceed $750,000 in direct costs excluding consortium F&A in any year for the UH3 phase.
TBD
Applications are not being solicited at this time.
Please direct all inquiries to:
Shumin Wang, PhD
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
301-594-9001
Talley, Edmund, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
301 496 1917
[email protected]